Gilead Sciences, Inc. today announced that the European Commission (EC) has granted conditional marketing authorization for seladelpar for the treatment of primary biliary cholangitis (PBC) in ...
A cancer vaccine will be available to women within a few months in India, Union Minister of State for Health, Family Welfare ...
A transformational year with significant clinical advancement across differentiated obesity pipeline, while building the ...
No. 2 / 2025Zealand Pharma Announces Financial Results for the Full Year 2024A transformational year with significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback